Medicus Pharma Ltd. (MDCX)
0.26
-0.01
(-4.34%)
USD |
NASDAQ |
Aug 24, 16:00
0.256
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Total Liabilities (Quarterly) : 20.33M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.33M |
| March 31, 2026 | 4.299M |
| December 31, 2025 | 7.313M |
| September 30, 2025 | 7.749M |
| June 30, 2025 | 6.366M |
| March 31, 2025 | 3.510M |
| December 31, 2024 | 2.512M |
| September 30, 2024 | 1.650M |
| Date | Value |
|---|---|
| June 30, 2024 | 1.703M |
| March 31, 2024 | 1.179M |
| December 31, 2023 | 0.7816M |
| September 30, 2023 | 1.601M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 9.211M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 177.40M |
| enGene Therapeutics, Inc. | 52.36M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 53.38M |
| Psyence Biomedical Ltd. | 0.9431M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.11M |
| Shareholders Equity (Quarterly) | -1.243M |
| Debt to Equity Ratio | -12.27 |
| Current Ratio | 1.566 |
| Net Debt Paydown Yield | -11.14% |